Chicago, ILNCT07710105Now EnrollingIRB Ready

Multiple Sclerosis Clinical Trial in Chicago, IL

Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by Northwestern University

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access multiple sclerosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis treatment provided free

Apply for This Chicago Location

Check if you qualify for this multiple sclerosis clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Multiple Sclerosis Study in Chicago

Ocrevus Zunovo implementation, feasibility, acceptability, patient satisfaction, treatment persistence, and impact on MS disease outcomes will be analyzed in this mixed methods study. This study will incorporate clinical data and questionnaire results from MS patients who take Ocrevus Zunovo as well as qualitative interviews with MS patients, family members, and other individuals involved in Ocrevus Zunovo treatment. The purpose of this study is to synthesize implementation strategies that improve patient access to high-efficacy MS therapies in real-world settings.

Sponsor: Northwestern University

Who Can Participate

Inclusion Criteria

Age of 18 years or older
Resident of the USA
Seen at Northwestern Medicine
Meets diagnostic criteria (2024) for MS, either RMS or PPMS
Diagnosis of MS (G35) on file by a neurologist
Wants to start or restart a DMT for MS
Willing to be in a 12-month follow up study

Exclusion Criteria

Unclear diagnosis of MS
Incarcerated
Unable to provide informed consent
Current participant in an MS or any experimental therapy clinical trial
Unable to speak a language for which consent processes are available at Northwestern Hospitals
Currently taking a DMT that has not been washed out (e.g. recent treatment with Cladribine, Natalizumab, sphingosine 1-phosphate inhibitor, implying the last DMT is still actively immunosuppressing the patient)
Current chemotherapy
History of stem cell transplant, CAR-T or other chemo-ablative procedures
Unwilling to complete surveys over the course of the following 12 months
No access to computer or telephone
Prior allergic reaction or intolerance to Ocrelizumab IV or SubQ or any monoclonal antibody therapy
Hypogammaglobulinemia IgG level \<500
Leukopenia \<2.0
Active hepatitis or latent hepatitis B
Elevated liver enzymes 3 times the upper limit of normal
Tuberculosis
Current serious infection, e.g. COVID-19, shingles, active pneumonia, progressive multifocal leukoencephalopathy, etc.
Currently pregnant, breastfeeding, or a person of childbearing capacity who is sexually active without a documented plan of current contraceptive methods.
Any other diagnosis or reason deemed to make the participant unfit for participation by the study PI

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT07710105) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis Treatment Options in Chicago, IL

If you're searching for multiple sclerosis treatment options in Chicago, IL, this clinical trial (NCT07710105) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis clinical trials near you to find additional studies recruiting in your area.

More Multiple Sclerosis Trials in Chicago, IL

See all multiple sclerosis clinical trials recruiting in Chicago — not just this study.

Browse Multiple Sclerosis Trials in Chicago →

Browse More Trials by Condition

Multiple Sclerosis TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL